GlassScriptPhysician profile
Amy Russell
NPI 1376788588
$6,481.91
in general payments reported to CMS, 2019-2025
42 companies · $1,522 in 2025
The $1,522 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,315 · 2022: $699 · 2023: $1,151 · 2024: $1,795 · 2025: $1,522.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,469.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,468.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,839.02 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,073.01 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Pfizer INC. | $372.12 | 2021-2025 | |
| Novo Nordisk INC | $300.58 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Phathom Pharmaceuticals, INC. | $268.15 | 2024-2025 | Voquezna |
| Amgen INC. | $202.92 | 2021-2025 | Repatha, Repatha, Otezla |
| Amarin Pharma, INC. | $187.24 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $182.96 | 2022-2024 | Caplyta |
| Janssen Pharmaceuticals, INC | $166.64 | 2022-2025 | Spravato |
| Glaxosmithkline, LLC. | $160.76 | 2023-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $144.13 | 2023-2025 | |
| Corcept Therapeutics | $116.19 | 2025 | Korlym |
| Merck Sharp & Dohme LLC | $108.79 | 2021-2025 | Gardasil 9, Capvaxive, Gardasil |
| Takeda Pharmaceuticals U.S.A., INC. | $101.38 | 2021-2024 | Trintellix |
| Teva Pharmaceuticals USA, INC. | $98.81 | 2022-2025 | Austedo Xr, Austedo, Ajovy |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Russell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.